Skip to main content
. 2004 Mar 18;6(3):R250–R255. doi: 10.1186/ar1170

Figure 1.

Figure 1

The drug development sequence. Note that the drug sponsor accumulates large amounts of data about the drug, and has eliminated the least promising agents before the design process for randomized controlled trials occurs.